Pompe disease: A neuromuscular disease with respiratory muscle involvement

被引:88
作者
Mellies, Uwe [1 ]
Lofaso, Frederic [2 ,3 ,4 ]
机构
[1] Univ Essen Gesamthsch, Childrens Hosp, Dept Pediat Pulmonol & Sleep Med, D-45122 Essen, Germany
[2] Dept Physiol Funct Testing, Garches, France
[3] Ctr Technol Innovat, Garches, France
[4] Hop Henri Mondor, INSERM, UMR 841, F-94010 Creteil, France
关键词
Acid maltase deficiency; Glycogen storage disease type II; Pompe disease; Respiratory complications; Type II glycogenosis; ACID MALTASE DEFICIENCY; ALPHA-GLUCOSIDASE; NATURAL-HISTORY; INFANTILE; FAILURE; COUGH; INSUFFLATION; PREDICTORS; MANAGEMENT; WEAKNESS;
D O I
10.1016/j.rmed.2008.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pompe disease is a single disease continuum that includes variable neuromuscular symptoms and rates of progression. However, specific clinical features, such as an early onset of respiratory problems preceding limb muscular weakness, distinguish Pompe disease from other neuromuscular diseases in which respiratory insufficiency occurs after loss of ambutation. The management of Pompe disease also differs from other neuromuscular diseases in that specific treatment is now available, making early recognition of the disease a priority. The results from clinical trials with recombinant human acid alpha-glucosidase have been published, and they show promising results with regards to the improvement of respiratory function in patients with Pompe disease. This review aims to give an overview of Pompe disease and to describe the current concepts of the disease. A focus is placed on the pathophysiology and clinical presentation of respiratory muscle involvement in adults. Additionally, new approaches and therapies available for the management of respiratory complications observed in Pompe disease are discussed in detail. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:477 / 484
页数:8
相关论文
共 56 条
  • [1] Akcam M, 2004, SAUDI MED J, V25, P2022
  • [2] Electrophysiologic techniques for the assessment of respiratory muscle function
    Aldrich, TK
    Sinderby, C
    McKenzie, DK
    Estenne, M
    Gandevia, SC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) : 548 - +
  • [3] Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling
    Ausems, MGEM
    Verbiest, J
    Hermans, MMP
    Kroos, MA
    Beemer, FA
    Wokke, JHJ
    Sandkuijl, LA
    Reuser, AJJ
    van der Ploeg, AT
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (06) : 713 - 716
  • [4] Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure - A different approach to weaning
    Bach, JR
    Saporito, LR
    [J]. CHEST, 1996, 110 (06) : 1566 - 1571
  • [5] Burghaus L, 2006, NERVENARZT, V77, P181, DOI 10.1007/s00115-005-2005-7
  • [6] Physical therapy management of Pompe disease
    Case, Laura Elizabeth
    Kishnani, Priya Sunil
    [J]. GENETICS IN MEDICINE, 2006, 8 (05) : 318 - 327
  • [7] Diaphragmatic insufficiency in REM sleep
    Culebras, A
    [J]. SLEEP MEDICINE, 2004, 5 (04) : 337 - 338
  • [8] Predictors of severe chest infections in pediatric neuromuscular disorders
    Dohna-Schwake, C.
    Ragette, R.
    Teschler, H.
    Voit, T.
    Mellies, U.
    [J]. NEUROMUSCULAR DISORDERS, 2006, 16 (05) : 325 - 328
  • [9] IPPB-assisted coughing in neuromuscular disorders
    Dohna-Schwake, Christian
    Ragette, Regine
    Teschler, Helmut
    Voit, Thomas
    Mellies, Uwe
    [J]. PEDIATRIC PULMONOLOGY, 2006, 41 (06) : 551 - 557
  • [10] Clinical presentation and disease progression in late-onset Pompe disease
    Escolar, D. M.
    Wokke, J. H. J.
    Pestronk, A.
    Carter, G. T.
    Jaffe, K. M.
    Laforet, P.
    [J]. NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 654 - 654